WITTMAN VANESSA AMES sold $806K of OSCR
WITTMAN VANESSA AMES sold 25,000 shares of Oscar Health, Inc. (OSCR) at $32.24 ($0.81M total) on 2026-09-18 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a data point for monitoring insider activity but does not constitute a material corporate event.
Market read
Provides a fresh insider transaction for Oscar Health, useful for short‑term monitoring but limited trading significance.
What to watch
The director retains a sizable stake (112,121 shares) and the sale was pre‑arranged, reducing informational asymmetry.
Background
SEC Form 4 filings disclose insider transactions and are primary sources for new corporate ownership changes.
Ticker impact
Director Vanessa Wittman Ames sold 25,000 shares of Oscar Health for $806K via a 10b5-1 plan.
Potential slight downward pressure, likely within normal volatility range.
A $806K sale represents ~0.7% of the insider's post‑transaction holdings and is a routine 10b5‑1 execution.
Market effects
Minimal impact on the health‑tech sector; insider sales are common and not sector‑wide signals.
No notable regional effect; the filing is specific to Oscar Health.
Limited global relevance; only relevant to investors tracking Oscar Health.
Counterpoint
The sale could be a routine liquidity event rather than a lack of confidence, so price impact may be negligible.
Key entities
- CompanyOscar Health, Inc.
US‑listed health‑tech insurer (ticker OSCR).
- IndividualVanessa Wittman Ames
Director of Oscar Health executing a 10b5‑1 sale.
